Deciphering how the APOBEC3 antiviral immune response drives lung cancer.

Lung cancer is often diagnosed at a late stage once tumours no longer respond to treatment. Recent lung cancer screening programmes in the UK do reduce mortality, but deciphering the very early changes in normal tissue that increase cancer risk will further identify novel therapeutic targets for cancer prevention that could substantially reduce…